Insuline Medical Stock Annual Yield
| INSL Stock | ILS 196.00 20.90 9.64% |
Insuline Medical fundamentals help investors to digest information that contributes to Insuline Medical's financial success or failures. It also enables traders to predict the movement of Insuline Stock. The fundamental analysis module provides a way to measure Insuline Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insuline Medical stock.
Insuline |
Insuline Medical Company Annual Yield Analysis
Insuline Medical's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Insuline Medical has an Annual Yield of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Insuline Fundamentals
| Price To Earning | (40.77) X | |||
| Revenue | 40 K | |||
| EBITDA | (6.82 M) | |||
| Net Income | (7.01 M) | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 2.86 X | |||
| Current Ratio | 0.98 X | |||
| Book Value Per Share | (0.16) X | |||
| Cash Flow From Operations | (7.68 M) | |||
| Earnings Per Share | (30.78) X | |||
| Number Of Employees | 26 | |||
| Beta | 1.79 | |||
| Market Capitalization | 36.33 M | |||
| Total Asset | 1.58 M | |||
| Retained Earnings | (158 M) | |||
| Working Capital | (1000 K) | |||
| Current Asset | 8 M | |||
| Current Liabilities | 9 M | |||
| Net Asset | 1.58 M |
About Insuline Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insuline Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insuline Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insuline Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Insuline Stock
Insuline Medical financial ratios help investors to determine whether Insuline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Insuline with respect to the benefits of owning Insuline Medical security.